Data / Form D filings / FENNEC PHARMACEUTICALS INC.
FENNEC PHARMACEUTICALS INC.: Form D filings
FENNEC PHARMACEUTICALS INC., a biotechnology company in Research Triangle Park, NC, filed 3 Form D notices with the SEC between 2013 and 2017. The latest, on June 8, 2017, reports $7.6 million sold of a $7.6 million offering to 7 investors.
Find out what FENNEC PHARMACEUTICALS INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 68 TW ALEXANDER DRIVE, Research Triangle Park, NC, 27709
- Phone
- (919) 636-4530
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1211583
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2017 | New notice | $7,600,000 | $7,600,000 | $0 | 7 | Jun 8, 2017 | sec.gov |
| Dec 15, 2014 | New notice | $2,200,000 | $2,200,000 | $0 | 22 | Dec 3, 2014 | sec.gov |
| Nov 27, 2013 | New notice | $1,600,000 | $1,600,000 | $0 | 8 | Nov 22, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adrian Haigh | Director | |
| Steven Skolsky | Director | |
| Chris Rallis | Director | |
| Krysia Lynes | Executive Officer | |
| Rostislav Raykov | Executive Officer, Director | |
| Khalid Islam | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jun 5, 2017 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what FENNEC PHARMACEUTICALS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.